Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Vericel Corporation stock
Learn how to easily invest in Vericel Corporation stock.
Vericel Corporation is a biotechnology business based in the US. Vericel Corporation shares (VCEL) are listed on the NASDAQ and all prices are listed in US Dollars. Vericel Corporation employs 273 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Vericel Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – VCEL – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Vericel Corporation stock price (NASDAQ: VCEL)Use our graph to track the performance of VCEL stocks over time.
Vericel Corporation shares at a glance
|Latest market close||$33.60|
|52-week range||$31.38 - $68.94|
|50-day moving average||$38.71|
|200-day moving average||$49.71|
|Wall St. target price||$53.96|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.01|
Buy Vericel Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Vericel Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Vericel Corporation price performance over time
|1 week (2022-01-15)||N/A|
|1 month (2021-12-22)||-16.98%|
|3 months (2021-10-26)||-33.88%|
|6 months (2021-07-26)||-34.93%|
|1 year (2021-01-26)||-17.75%|
|2 years (2020-01-24)||99.76%|
|3 years (2019-01-25)||94.22%|
|5 years (2017-01-26)||1,167.92%|
Is Vericel Corporation stock undervalued or overvalued?
Valuing Vericel Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Vericel Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Vericel Corporation's P/E ratio
Vericel Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 6786x. In other words, Vericel Corporation shares trade at around 6786x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Vericel Corporation's EBITDA
Vericel Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.1 million.
The EBITDA is a measure of a Vericel Corporation's overall financial performance and is widely used to measure a its profitability.
Vericel Corporation financials
|Revenue TTM||$153.8 million|
|Operating margin TTM||0.19%|
|Gross profit TTM||$84.2 million|
|Return on assets TTM||0.1%|
|Return on equity TTM||0.16%|
|Market capitalisation||$1.6 billion|
TTM: trailing 12 months
Vericel Corporation share dividends
We're not expecting Vericel Corporation to pay a dividend over the next 12 months.
Have Vericel Corporation's shares ever split?
Vericel Corporation's shares were split on a 1:20 basis on 15 October 2013. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Vericel Corporation shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Vericel Corporation shares which in turn could have impacted Vericel Corporation's share price.
Vericel Corporation share price volatility
Over the last 12 months, Vericel Corporation's shares have ranged in value from as little as $31.3793 up to $68.94. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vericel Corporation's is 1.9681. This would suggest that Vericel Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Vericel Corporation overview
Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product includes, NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. .
Vericel Corporation in the news
Cordant, Inc. Buys Dimensional International Value ETF, iShares Core MSCI International ...
Netflix shares fall near pre-pandemic level as investors fear slowing subscriber growth, competition
Stocks making the biggest moves midday: Netflix, Kohl's, Wynn Resorts, General Motors and more
Frequently asked questionsWhat percentage of Vericel Corporation is owned by insiders or institutions?
Currently 1.177% of Vericel Corporation shares are held by insiders and 110.648% by institutions. How many people work for Vericel Corporation?
Latest data suggests 273 work at Vericel Corporation. When does the fiscal year end for Vericel Corporation?
Vericel Corporation's fiscal year ends in December. Where is Vericel Corporation based?
Vericel Corporation's address is: 64 Sidney Street, Cambridge, MA, United States, 02139 What is Vericel Corporation's ISIN number?
Vericel Corporation's international securities identification number is: US92346J1088 What is Vericel Corporation's CUSIP number?
Vericel Corporation's Committee on Uniform Securities Identification Procedures number is: 00253U107
More guides on Finder
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Dogecoin jumps 10% on word you can use it to buy Tesla merch
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
Thursday’s top U.S. stocks: Taiwan Semiconductor Manufacturing Company Ltd. (TSM ↑8.4%), Lam Research Corporation (LRCX ↑6.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Ask an Expert